BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.5733
+0.0056 (0.99%)
Jan 2, 2026, 2:06 PM EST - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $33.85 million as of January 2, 2026. Its market cap has decreased by -51.72% in one year.
Market Cap
33.85M
Enterprise Value
32.38M
1-Year Change
-51.72%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $33.85M, a decrease of -94.14%. That is a compound annual growth rate of -43.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |